Page last updated: 2024-10-14

tryptophyl-histidine

Cross-References

ID SourceID
PubMed CID18218250
SCHEMBL ID17274594
MeSH IDM0497166

Synonyms (9)

Synonym
wh
tryptophylhistidine
KBUBZAMBIVEFEI-UHFFFAOYSA-N
SCHEMBL17274594
wh dipeptide
tryptophan-histidine dipeptide
tryptophan histidine dipeptide
w-h dipeptide
tryptophyl-histidine

Bioavailability

ExcerptReference
" This suggests that the bioavailability of peptides may be determined in part by their protease resistance in the intestinal membrane."( Visualized absorption of anti-atherosclerotic dipeptide, Trp-His, in Sprague-Dawley rats by LC-MS and MALDI-MS imaging analyses.
Akiyama, S; Hong, SM; Hu, QQ; Matsui, T; Tanaka, M, 2015
)

Dosage Studied

ExcerptReference
" After 9-week administration, en face analyses provided the first direct evidence that the atherosclerotic lesion area was significantly reduced by 27 and 38 % for Trp-His dosed at 10 and 100 mg/kg per d, respectively, compared with the control group."( Vasodilating dipeptide Trp-His can prevent atherosclerosis in apo E-deficient mice.
Fujimoto, Y; Imaizumi, K; Matsui, T; Matsumoto, K; Sato, M; Tanaka, M; Watanabe, S; Yamada, Y, 2010
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's7 (77.78)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]